Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Morris

Showing results (321-330 of 435) with videos related to

Pageof 44
Sort By:
Journal of Gastrointestinal Oncology|February 4, 2014
Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastasesAkshat Saxena, Terence C Chua, Francis C Chu, et al.
Anticancer Research|May 6, 2020
Impact of Cytoreductive Surgery and HIPEC on Intraoperative Gastrointestinal Wall Thickness and Patient OutcomesMichelle Zhiyun Chen, Daniel L Chan, Mohammad S Alshahrani, et al.
Journal of Surgical Oncology|July 23, 2011
Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosisYvonne L B Klaver, Terence C Chua, Ignace H J T de Hingh, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 25, 2019
Intraoperative packed red blood cell transfusion (iPRBT) and PCI-normalised iPRBT rates (iPRBT/PCI ratio) negatively affect short- and long-term outcomes of patients undergoing cytoreductive surgery and intraperitoneal chemotherapy - An analysis of 880 patientsOliver M Fisher, Nayef A Alzahrani, Mathew A Kozman, et al.
American Journal of Cancer Research|June 7, 2021
Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition <i>in vivo</i> in human colon cancer cell line LS174TAhmed H Mekkawy, Krishna Pillai, Samina Badar, et al.
Cancers|July 14, 2023
Intraperitoneal BromAc<sup>®</sup> Does Not Interfere with the Healing of Colon AnastomosisAhmed H Mekkawy, Mohammad Breakeit, Krishna Pillai, et al.
Annals of Surgical Oncology|July 27, 2007
A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancerTristan D Yan, Deborah Black, Paul H Sugarbaker, et al.
In Vivo (Athens, Greece)|September 13, 2022
Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Mohammad Breakeit, Daniel Liu, Adrian Cheng, et al.
Surgical Innovation|January 26, 2010
Hand-assisted laparoscopic partial nephrectomy: a controlled study of bipolar inline radiofrequency ablation device in SwinePeng Yao, Ray Stanton, Terence C Chua, et al.
Discover Oncology|February 24, 2022
The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 studyKevin Ke, Krishna Pillai, Ahmed H Mekkawy, et al.
Pageof 44

Showing results (321-330 of 435) with videos related to

Sort By:
Pageof 44
Journal of Gastrointestinal Oncology|February 4, 2014
Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastasesAkshat Saxena, Terence C Chua, Francis C Chu, et al.
Anticancer Research|May 6, 2020
Impact of Cytoreductive Surgery and HIPEC on Intraoperative Gastrointestinal Wall Thickness and Patient OutcomesMichelle Zhiyun Chen, Daniel L Chan, Mohammad S Alshahrani, et al.
Journal of Surgical Oncology|July 23, 2011
Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosisYvonne L B Klaver, Terence C Chua, Ignace H J T de Hingh, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 25, 2019
Intraoperative packed red blood cell transfusion (iPRBT) and PCI-normalised iPRBT rates (iPRBT/PCI ratio) negatively affect short- and long-term outcomes of patients undergoing cytoreductive surgery and intraperitoneal chemotherapy - An analysis of 880 patientsOliver M Fisher, Nayef A Alzahrani, Mathew A Kozman, et al.
American Journal of Cancer Research|June 7, 2021
Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition <i>in vivo</i> in human colon cancer cell line LS174TAhmed H Mekkawy, Krishna Pillai, Samina Badar, et al.
Cancers|July 14, 2023
Intraperitoneal BromAc<sup>®</sup> Does Not Interfere with the Healing of Colon AnastomosisAhmed H Mekkawy, Mohammad Breakeit, Krishna Pillai, et al.
Annals of Surgical Oncology|July 27, 2007
A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancerTristan D Yan, Deborah Black, Paul H Sugarbaker, et al.
In Vivo (Athens, Greece)|September 13, 2022
Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Mohammad Breakeit, Daniel Liu, Adrian Cheng, et al.
Surgical Innovation|January 26, 2010
Hand-assisted laparoscopic partial nephrectomy: a controlled study of bipolar inline radiofrequency ablation device in SwinePeng Yao, Ray Stanton, Terence C Chua, et al.
Discover Oncology|February 24, 2022
The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 studyKevin Ke, Krishna Pillai, Ahmed H Mekkawy, et al.
Pageof 44